Mark Savercool, a manufacturing technician, works in Pfizer's Solid Dosage Manufacturing building in Groton Thursday, preparing a tablet press for manufacturing tablets. A similar machine in the SDM building was used for Xalkori.
Rich Hutchins, Xalkori pharmaceutical sciences leader, left, and Mark Maloney, an associate research fellow, discuss the device created to manufacture a drug's active ingredient continually, not in batches, in the Engineering Technologies Lab at Pfizer in Groton Thursday. The process for Xalkori was done in Sandwich, England, in partnership with scientists at the Groton site.
Counter clockwise from right, Xiaoping Cao, material science leader; Rolf Larsen, principal scientist; Jeffrey Moriarty, scientist; Brian Samas, crystalographer; and Mahesh Krishnan, associate research fellow; in the X-Ray Lab of at Pfizer in Groton. They all worked on the drug Xalkori. The image on the computer screen is an example of a molecule as it appears in a crystal structure. The unit in the background is a powder x-ray diffractometer, which provides a fingerprint that will be used to manufacture the drug.
Rich Hutchins, Xalkori pharmaceutical sciences leader, right, and Rosanne Salisbury, scientist, left, explain how this equipment in Pfizer's Dissolution Lab in Groton monitors the release rate of a drug by simulating its release into the body.
Eddie Adap, left, and Mark Savercool, right, both manufacturing technicians, work in the Solid Dosage Manufacturing Building at Pfizer in Groton, preparing a tablet press for manufacturing tablets Thursday. A similar machine in the SDM building was to make Xalkori.
J.C. Miranda, left, manufacturing technician, and Elvyn Rodriguez, principal scientist, work with a small scale encapsulation machine in a lab in the Solid Dosage Manufacturing Building at Pfizer in Groton Thursday. The machine was used for making very early clinical supplies of the drug Xalkori.
Pfizer, despite announced research cutbacks locally over the next year, is banking on its 4,000 or so scientists in Groton to be the engine that drives new drugs to market.